ArticleDiscover oncology2026

Development and validation of a prognosis model for low-grade gliomas based on metabolic gene risk scoring and immune microenvironment interaction.

Haobin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.